FederalUS CongressReferred
H.R. 10369: Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
Rep. Ryan Mackenzie (R-PA)
H.R. 10369 status: Referred.
Checking for a saved analysis
Rep. Ryan Mackenzie (R-PA)
H.R. 10369 status: Referred.